CRMDライブシグナル | Getagraph.comで利益を最大化

売る 107623 min ago

@ $3.15

発行日: 14 2月 2024 @ 23:32

リターン: 68.57%

前回のシグナル: 2月 13 - 03:31

前回のシグナル: 買う

リターン: -4.11 %

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	312 826
平均出来高	608 923
時価総額	291.05M
EPS	$0 ( 2024-03-12 )
次の収益日	( $-0.280 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.25
ATR14	$0.00700 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-05	Lefkowitz Steven W	Buy	30 000	Stock Option (Right to Buy Common Stock)
2024-03-05	Stewart Robert A	Buy	30 000	Stock Option (Right to Buy Common Stock)
2024-03-05	Kaplan Myron	Buy	30 000	Stock Option (Right to Buy Common Stock)
2024-03-05	Dillione Janet	Buy	30 000	Stock Option (Right to Buy Common Stock)
2024-03-05	Dunton Alan W	Buy	30 000	Stock Option (Right to Buy Common Stock)

INSIDER POWER
93.16
Last 95 transactions
Buy: 4 530 513 \| Sell: 123 432

ボリューム相関

長: 0.19 (neutral)

短: 0.95 (very strong)

Signal:(59.891) Expect same movement, but be aware

CorMedix Inc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

CorMedix Inc 相関 - 通貨/商品

0.37
( neutral )

0.22
( neutral )

0.00
( neutral )

0.34
( neutral )

0.00
( neutral )

0.09
( neutral )

CorMedix Inc 財務諸表

Annual	2023
収益:	$0
総利益:	$-205 562 (0.00 %)
EPS:	$-0.910

FY	2023
収益:	$0
総利益:	$-205 562 (0.00 %)
EPS:	$-0.910

FY	2022
収益:	$65 408.00
総利益:	$61 674.00 (94.29 %)
EPS:	$-0.740

FY	2021
収益:	$190 936
総利益:	$41 998.00 (22.00 %)
EPS:	$-0.750

Financial Reports:

No articles found.

CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.